Built for PSX investors
Your market watch, portfolio and news desk in one app.
Follow live PSX prices, track holdings, read business news, and keep your watchlist close before the market moves.
Built for PSX investors
Follow live PSX prices, track holdings, read business news, and keep your watchlist close before the market moves.
BFBIOBF Biosciences LtdBF Biosciences Limited announced un-audited financial results for the quarter ended 31 March 2026. Using the quarter columns stated in the DPS title, revenue rose sharply year-on-year to Rs. 2.14 billion from Rs. 1.50 billion and gross profit increased to Rs. 973.45 million from Rs. 549.45 million, but profit after tax declined to Rs. 117.65 million from Rs. 124.53 million and EPS fell to Rs. 1.33 from Rs. 1.59. Balance sheet figures show cash and bank balances of Rs. 288.13 million as at 31 March 2026 versus Rs. 344.47 million at 30 June 2025, while short-term borrowings increased materially to Rs. 216.08 million from Rs. 29.36 million.
| Metric | Previous31 March 2025 | Current31 March 2026 | Change |
|---|---|---|---|
| Revenue - net | 1,500,469,043 | 2,135,491,839 | +42.3% |
| Gross profit | 549,446,151 | 973,450,486 | +77.2% |
| Profit from operations | 230,888,828 | 225,345,238 | -2.4% |
| Profit after taxation | 124,526,793 | 117,646,347 | -5.5% |
| Earnings per share - basic and diluted | 1.59 | 1.33 | -16.4% |
| Finance cost | (30,043,173) | (23,169,655) | -22.9% |
| Cash and bank balances | 344,470,143 | 288,133,187 | -16.4% |
| Short term borrowings - secured | 29,362,548 | 216,080,283 | +635.9% |
Highlights summarize the key points from the company's official PSX filing. View the original filing for the complete details before making financial decisions.
Get Investify
The information on Investify is for informational purposes only and is not financial, investment, legal or tax advice. Market data, announcements, news, highlights, Buy/Sell/Neutral labels and other values may be sourced from or relate to Recube Technologies LLP, third-party providers and automated systems; none of these parties guarantees the timeliness, accuracy, completeness, correct sequencing, reliability or availability of such information. Nothing on the website or app is an offer, solicitation, recommendation or advice to buy, sell, hold or enter into any transaction. Investing involves risk, and users are responsible for verifying original sources and consulting qualified advisers before making investment decisions.
© 2026 Investify. All rights reserved.